Subpart H. Subpart H—Health Effects Test Guidelines
- § 799.9110 - TSCA acute oral toxicity.
- § 799.9120 - TSCA acute dermal toxicity.
- § 799.9130 - TSCA acute inhalation toxicity.
- § 799.9135 - TSCA acute inhalation toxicity with histopathology.
- § 799.9305 - TSCA Repeated dose 28-day oral toxicity study in rodents.
- § 799.9310 - TSCA 90-day oral toxicity in rodents.
- § 799.9325 - TSCA 90-day dermal toxicity.
- § 799.9346 - TSCA 90-day inhalation toxicity.
- § 799.9355 - TSCA reproduction/developmental toxicity screening test.
- § 799.9365 - TSCA combined repeated dose toxicity study with the reproduction/developmental toxicity screening test.
- § 799.9370 - TSCA prenatal developmental toxicity.
- § 799.9380 - TSCA reproduction and fertility effects.
- § 799.9410 - TSCA chronic toxicity.
- § 799.9420 - TSCA carcinogenicity.
- § 799.9430 - TSCA combined chronic toxicity/carcinogenicity.
- § 799.9510 - TSCA bacterial reverse mutation test.
- § 799.9530 - TSCA in vitro mammalian cell gene mutation test.
- § 799.9537 - TSCA in vitro mammalian chromosome aberration test.
- § 799.9538 - TSCA mammalian bone marrow chromosomal aberration test.
- § 799.9539 - TSCA mammalian erythrocyte micronucleus test.
- § 799.9620 -
- § 799.9630 - TSCA developmental neurotoxicity.
- § 799.9748 - TSCA metabolism and pharmacokinetics
- § 799.9780 - TSCA immunotoxicity.